相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells
Dipankar Ray et al.
GASTROENTEROLOGY (2020)
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Takashi Kojima et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer
Andrew E. Blum et al.
GASTROENTEROLOGY (2019)
Interleukin-18 in Health and Disease
Koubun Yasuda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naive Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
Maria C. Svensson et al.
FRONTIERS IN ONCOLOGY (2019)
Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer
Taisuke Yagi et al.
EUROPEAN JOURNAL OF CANCER (2019)
High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome
Natasha Stephens Muench et al.
GASTROENTEROLOGY (2019)
Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis
Jiangfen Li et al.
FUTURE ONCOLOGY (2019)
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
Eva A. Ebbing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus The Phase 2 KEYNOTE-180 Study
Manish A. Shah et al.
JAMA ONCOLOGY (2019)
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Kohei Shitara et al.
LANCET (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease
Arianne C. Richard et al.
PLOS GENETICS (2018)
Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
Maartje C. A. Wouters et al.
CLINICAL CANCER RESEARCH (2018)
Spatial and phenotypic immune profiling of metastatic colon cancer
Jenny Lazarus et al.
JCI INSIGHT (2018)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
The relationship between eosinophilic esophagitis and esophageal cancer
A. Syed et al.
DISEASES OF THE ESOPHAGUS (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction
Juliana Knief et al.
ANTICANCER RESEARCH (2016)
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil
Junpu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
Erika Vacchelli et al.
ONCOTARGET (2015)
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
Murali Janakiram et al.
CLINICAL CANCER RESEARCH (2015)
The natural history of steroid-naive eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years
Seth Lipka et al.
GASTROINTESTINAL ENDOSCOPY (2014)
IL-6-stimulated CD11b+CD14+HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
Miao-Fen Chen et al.
ONCOTARGET (2014)
Mice That Express Human Interleukin-8 Have Increased Mobilization of Immature Myeloid Cells, Which Exacerbates Inflammation and Accelerates Colon Carcinogenesis
Samuel Asfaha et al.
GASTROENTEROLOGY (2013)
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
Austin M. Dulak et al.
NATURE GENETICS (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Ruihua Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Myeloid derived suppressor cells: Targets for therapy
Todd J. Waldron et al.
ONCOIMMUNOLOGY (2013)
Interleukin-15 biology and its therapeutic implications in cancer
Jason C. Steel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer
Zhi-Jun Jiao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Incidence of Adenocarcinoma among Patients with Barrett's Esophagus
Frederik Hvid-Jensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The E3 Ubiquitin Ligase GRAIL Regulates T Cell Tolerance and Regulatory T Cell Function by Mediating T Cell Receptor-CD3 Degradation
Roza I. Nurieva et al.
IMMUNITY (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation
Taylor H. Schreiber et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases
Francoise Meylan et al.
IMMUNITY (2008)
Expression Pattern of Immune Suppressive Cytokines and Growth Factors in Oesophageal Adenocarcinoma Reveal a Tumour Immune Escape-promoting Microenvironment
F. Milano et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance
Ljubov Simson et al.
JOURNAL OF IMMUNOLOGY (2007)
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
K Yamazaki et al.
HUMAN MOLECULAR GENETICS (2005)
Regulation of IFN-γ production by B effector 1 cells:: Essential roles for T-bet and the IFN-γ receptor
DP Harris et al.
JOURNAL OF IMMUNOLOGY (2005)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis
AH Li et al.
JOURNAL OF IMMUNOLOGY (2003)
Natural history of primary eosinophilic esophagitis: A follow-up of 30 adult patients for up to 11.5 years
A Straumann et al.
GASTROENTEROLOGY (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants
RC Fitzgerald et al.
GUT (2002)
TL1A is a TNF-like ligand and functions as a T cell for DR3 and TR6/DcR3 costimulator
TS Migone et al.
IMMUNITY (2002)
Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro
R Brew et al.
CYTOKINE (2000)
分享论文
